<DOC>
	<DOCNO>NCT02536417</DOCNO>
	<brief_summary>The purpose study determine melatonin administration end-of-life patient effective prevent development delirium compare receive treatment . Delirium difficult control symptom commonly see patient end-of-life . A person delirious unable think clearly make sense go around him/her .</brief_summary>
	<brief_title>Efficacy Melatonin Decreasing Incidence Delirium End Life Patients</brief_title>
	<detailed_description />
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Patients admit test site Adult patient 19 year age Patients provide informed consent Patients able tolerate oral medication Patients exist delirium dementia admission Patients poor clinical performance Patients take melatonin prior admission Patients take medication interact melatonin Patients unable provide inform consent Patients enrol research study involve drugs/devices</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Melatonin</keyword>
	<keyword>Delirium prevention</keyword>
	<keyword>End-of-life</keyword>
</DOC>